Figure 2.
Early conversion to belatacept as a risk factor for an opportunistic infection (OPI). Kaplan–Meier analysis curve of OPI-free survival in kidney transplant recipients converted earlier (<6-months) and later (≥6-months) to belatacept (A) and of recipients converted to belatacept before <8-months and after ≥8-months (B).